Cargando…
Targeting long noncoding RNA-AQP4-AS1 for the treatment of retinal neurovascular dysfunction in diabetes mellitus
BACKGROUND: Diabetic retinopathy (DR) is a leading cause of blindness in the working-age population, which is characterized by retinal neurodegeneration and vascular dysfunction. Long non-coding RNAs (LncRNAs) have emerged as critical regulators in several biological processes and disease progressio...
Autores principales: | Li, Xiumiao, Zhu, Junya, Zhong, Yuling, Liu, Chang, Yao, Mudi, Sun, Yanan, Yao, Wen, Ni, Xisen, Zhou, Fen, Yao, Jin, Jiang, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850682/ https://www.ncbi.nlm.nih.gov/pubmed/35172268 http://dx.doi.org/10.1016/j.ebiom.2022.103857 |
Ejemplares similares
-
The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
por: Yao, Yajun, et al.
Publicado: (2022) -
The retinal neurovascular coupling is impaired in men with vasculogenic erectile dysfunction
por: Borrelli, Enrico, et al.
Publicado: (2023) -
EYE-503: A Novel Retinoic Acid Drug for Treating Retinal Neurodegeneration
por: Liu, Sha, et al.
Publicado: (2023) -
Hyperglycemia-regulated tRNA-derived fragment tRF-3001a propels neurovascular dysfunction in diabetic mice
por: Zhu, Jun-Ya, et al.
Publicado: (2023) -
Editorial: Neurovascular dysfunction after stroke
por: Hu, Qin, et al.
Publicado: (2022)